Analysis of trichotomous pharmaceutical endpoints

Area of Science:

• Biostatistics
• Clinical Trials
• Statistical Analysis

Background:

• Many clinical trial endpoints use ordered categorical scales (e.g., tumor response, TIMI flow, ACR criteria).
• Researchers often oversimplify these outcomes into 2x2 tables for basic statistical tests (chi-square, Fisher's exact).
• This simplification can lead to a loss of statistical power and information.

Purpose of the Study:

• To address the lack of guidance in selecting adaptive parameters for ordered categorical endpoints when prior information is available.
• To offer an objective approach for parameter selection in adaptive testing.
• To illustrate the proposed method with real-world clinical trial data.

Main Methods:

• The study focuses on adaptive tests designed for ordered categorical data.
• It leverages prior knowledge about the direction and confidence of treatment effects.
• An objective method for selecting adaptive parameters is proposed and demonstrated.

Main Results:

• Adaptive tests provide exact statistical analysis for ordered categorical endpoints.
• These tests balance global power with specific alternative power.
• The proposed objective approach facilitates informed parameter selection for adaptive tests.

Conclusions:

• The developed objective approach enhances the application of adaptive tests for ordered categorical data.
• This method improves the statistical rigor and power of clinical trial analyses.
• Utilizing prior information objectively leads to more appropriate and powerful statistical testing.